CN104163798A - Synthesis method of 3-amino-8-trifluoromethyl quinoline - Google Patents

Synthesis method of 3-amino-8-trifluoromethyl quinoline Download PDF

Info

Publication number
CN104163798A
CN104163798A CN201410363728.0A CN201410363728A CN104163798A CN 104163798 A CN104163798 A CN 104163798A CN 201410363728 A CN201410363728 A CN 201410363728A CN 104163798 A CN104163798 A CN 104163798A
Authority
CN
China
Prior art keywords
trifluoromethylquinocarboxylic
amino
reaction
synthetic method
bromo
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201410363728.0A
Other languages
Chinese (zh)
Inventor
王玲
徐卫良
徐炜政
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SUZHOU KANGRUN PHARMACEUTICALS Inc
Original Assignee
SUZHOU KANGRUN PHARMACEUTICALS Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SUZHOU KANGRUN PHARMACEUTICALS Inc filed Critical SUZHOU KANGRUN PHARMACEUTICALS Inc
Priority to CN201410363728.0A priority Critical patent/CN104163798A/en
Publication of CN104163798A publication Critical patent/CN104163798A/en
Pending legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D215/00Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/38Nitrogen atoms

Abstract

The invention relates to a synthesis method of 3-amino-8-trifluoromethyl quinoline. The synthesis method comprises the steps: carrying out a reaction of 8-trifluoromethyl quinoline with N-bromosuccinimide to generate 3-bromo-8-trifluoromethyl quinoline, then carrying out a reaction with tert-butyl carbamate in the presence of palladium acetate, 4,5-bis(diphenylphosphino)-9,9-dimethylxanthene and cesium carbonate to generate 3-tert-butoxycarbonyl amino-8-trifluoromethyl quinoline, and finally carrying out deamination protection on the compound in a mixed solvent of hydrochloric acid and methanol to obtain 3-amino-8-trifluoromethyl quinoline. The synthesis method has the advantages of high total yield (57.80%), convenient operation, simple post-treatment, no use of highly toxic reagents, and low requirements on equipment and environmental protection, and is suitable for mass production.

Description

The synthetic method of 3-amino-8-Trifluoromethylquinocarboxylic
Technical field
The invention belongs to pharmaceutical intermediate synthesis technical field, be specifically related to a kind of synthetic method of 3-amino-8-Trifluoromethylquinocarboxylic.
Background technology
3-amino-8-Trifluoromethylquinocarboxylic and intermediate thereof are important intermediates in organic synthesis and pharmaceutical chemistry.Set out with these compounds, can synthesize a series of molecule drug candidates with fine pharmaceutical activity.Up-to-date research shows, these candidate molecules are except the retina shedding isoreactivity that has angiogenesis inhibitor, anticoagulation, antitumor and anti metastasis and anti-diabetic and cause, can also be used for the disease (US20030144507 such as treatment of arthritis and the easy syndromes of intestines, US20040018192, WO2004069792).In recent years, thus seeking some active good screening of medicaments by 3-amino-8-Trifluoromethylquinocarboxylic and intermediate thereof are connected with some specific structures has become one of focus of pharmaceutical chemistry circle.
Synthesizing of 3-amino-8-Trifluoromethylquinocarboxylic, current main method is by o-trifluoromethyl aniline and ethoxy methylene diethyl condensation, product high temperature cyclisation in phenyl ether generates 4-oxo-8-Trifluoromethyl-1,4-dihydroquinoline-3-ethyl formate, then obtains intermediate 8-Trifluoromethylquinocarboxylic-3-ethyl formate with phosphorus oxychloride reaction and through catalytic hydrogenation dechlorination.The hydrolysis of 8-Trifluoromethylquinocarboxylic-3-ethyl formate obtains 8-Trifluoromethylquinocarboxylic-3-formic acid, and the latter reacts the 3-amino-8-Trifluoromethylquinocarboxylic that obtains Boc radical protection in DMF with DPPA.This compound is taken off protective material and is obtained 3-amino-8-Trifluoromethylquinocarboxylic under acidic conditions.There is following shortcoming in the method: (1) synthetic route is longer, and aftertreatment trouble, can not fairly largely produce; (2) in phenyl ether, condensation need to be carried out above at 250 DEG C, has very high danger; (3) use severe toxicity and to the disagreeableness phosphorus oxychloride of environment, and in catalytic hydrogenation dechlorination, produced the dihydroquindine derivates of a large amount of over reductions, caused yield on the low side, aftertreatment trouble; (4) in 8-Trifluoromethylquinocarboxylic-3-formic acid and DPPA rearrangement process, produce a large amount of gas, punching material easily occurs, reaction can only occur at small-scale.
Summary of the invention
The synthetic method that the object of the invention is to overcome the deficiencies in the prior art and provide a kind of 3-amino-8-Trifluoromethylquinocarboxylic, the method total recovery is high, easy to operate, aftertreatment is simple, do not use poisonous reagent, low to equipment and environmental requirement, be applicable to scale operation.
In order to realize foregoing invention object, the present invention by the following technical solutions:
The synthetic method of 3-amino-8-Trifluoromethylquinocarboxylic; react with N-bromosuccinimide in acetic acid by 8-Trifluoromethylquinocarboxylic and generate the bromo-8-Trifluoromethylquinocarboxylic of 3-; then with t-butyl carbamate in palladium, 4; two diphenylphosphine-9 of 5-; under the existence of 9-dimethyl oxa-anthracene and cesium carbonate, reaction generates the tertiary oxygen carbonyl amino-8-of 3-Trifluoromethylquinocarboxylic, and finally this compound deaminizating protection in the mixed solvent of hydrochloric acid and methyl alcohol obtains 3-amino-8-Trifluoromethylquinocarboxylic.
Reaction formula is as follows:
Concrete technology is as follows:
The first step is substitution reaction: reaction substrate is 8-Trifluoromethylquinocarboxylic (1), and replacement reagent is N-bromosuccinimide, and reaction solvent is acetic acid, and temperature of reaction is 110 DEG C, and the reaction times is 12h, obtains the bromo-8-Trifluoromethylquinocarboxylic of 3-; Wherein the mol ratio of 8-Trifluoromethylquinocarboxylic and N-bromosuccinimide is 1:1.2.
Second step is the bromo-8-Trifluoromethylquinocarboxylic of condensation reaction: 3-(2) with t-butyl carbamate in palladium, 4, two diphenylphosphine-9 of 5-, under the existence of 9-dimethyl oxa-anthracene and cesium carbonate, with 1,4-dioxane is reaction solvent, at 90 DEG C of reaction 4h, obtain the tertiary oxygen carbonyl amino-8-of 3-Trifluoromethylquinocarboxylic, wherein, the mol ratio of each substrate is the bromo-8-Trifluoromethylquinocarboxylic of 3-: t-butyl carbamate: cesium carbonate: 4, two diphenylphosphine-9 of 5-, 9-dimethyl oxa-anthracene: palladium=1:1.1:2:0.1:0.055.
The 3rd step is amino deprotection reaction: under normal temperature, 3-tertiary oxygen carbonyl amino-8-Trifluoromethylquinocarboxylic (3) is at the mixing solutions (V of methyl alcohol and hydrochloric acid methyl alcohol: V concentrated hydrochloric acid=1:1) in, reaction 2h obtains 3-amino-8-Trifluoromethylquinocarboxylic (4).
Synthetic method total recovery of the present invention high (57.80%), easy to operate, aftertreatment is simple, do not use poisonous reagent, low to equipment and environmental requirement, is applicable to scale operation.
Embodiment
Embodiment 1
The synthetic method of 3-amino-8-Trifluoromethylquinocarboxylic, technique is as follows:
Synthesizing of the bromo-8-Trifluoromethylquinocarboxylic of the first step: 3-
At 110 DEG C, in acetic acid (100mL) solution of 8-Trifluoromethylquinocarboxylic (10g, 0.05mol), add N-bromosuccinimide (10.7g, 0.06mol), mixture continues heated and stirred 12h at this temperature.After reacting completely, by acetic acid evaporate to dryness, and add ammoniacal liquor to pH=9 left and right.Mixed solution dichloromethane extraction, organic phase is washed with saturated sodium bicarbonate, after anhydrous sodium sulfate drying, is spin-dried for, and thick product is crossed post and is obtained the bromo-8-Trifluoromethylquinocarboxylic of 3-(10.9g, 78%).
1HNMR(400MHz,DMSO-d6):7.80-7.84(m,1H),8.23-8.38(m,2H),8.91(d,J=2.4Hz,1H),9.13(d,J=2.0Hz,1H)。
Synthesizing of the tertiary oxygen carbonyl amino-8-of second step: 3-Trifluoromethylquinocarboxylic
By bromo-3-8-Trifluoromethylquinocarboxylic (9g, 32.6 mmol), NH 2boc (4.2g, 36mmol), cesium carbonate (21.3g, 65mmol), palladium (0.5g, 1.8mmol) and Xantphots (2g, Isosorbide-5-Nitrae-dioxane (100mL) solution stirring reaction 4h at 90 DEG C 3.3mmol).After adding 200mL ethyl acetate, mixture is stirred to 10min, after mixture filters, organic phase is spin-dried for after drying.Thick product is crossed post and is obtained the tertiary oxygen carbonyl amino-8-of 3-Trifluoromethylquinocarboxylic (8g, 78%).
The 3rd step: 3-amino-8-trifluoromethyl synthetic
Add 50mL concentrated hydrochloric acid in methyl alcohol (50mL) solution of the tertiary oxygen carbonyl amino-8-Trifluoromethylquinocarboxylic of 3-(8g, 25.5mmol) after by mixture stirring at room temperature 2h.After reacting completely, by mixed solution evaporate to dryness, add 50mL water and 200mL ethyl acetate, and add ammoniacal liquor to pH=9 left and right.After aqueous phase separation, organic layer is spin-dried for, residue obtains 3-amino-8-Trifluoromethylquinocarboxylic (5.2g, 95%) by petroleum ether.
1HNMR(400MHz,DMSO-d6):5.88(s,2H),7.25(d,J=2.8Hz,1H),7.49(t,J=8Hz,16Hz,1H),7.69(d,J=7.2Hz,1H),7.90(d,J=8.4Hz,1H),8.57(d,J=2.8Hz,1H)。

Claims (7)

  1. The synthetic method of 1.3-amino-8-Trifluoromethylquinocarboxylic, is characterized in that: comprise the following steps:
    Step 1,8-Trifluoromethylquinocarboxylic and N-bromosuccinimide are under heating condition, and reaction generates the bromo-8-Trifluoromethylquinocarboxylic of 3-;
    Step 2, the bromo-8-Trifluoromethylquinocarboxylic of step 1 gained 3-and t-butyl carbamate are in palladium, 4, and two diphenylphosphine-9 of 5-under the existence of 9-dimethyl oxa-anthracene and cesium carbonate, are reacted and are generated the tertiary oxygen carbonyl amino-8-of 3-Trifluoromethylquinocarboxylic under heating condition;
    Step 3, under room temperature, the tertiary oxygen carbonyl amino-8-of step 2 gained 3-Trifluoromethylquinocarboxylic is under acidic conditions, and deaminizating protection obtains 3-amino-8-Trifluoromethylquinocarboxylic.
  2. 2. the synthetic method of 3-amino-8-Trifluoromethylquinocarboxylic according to claim 1, is characterized in that: the solvent that step 1 adopts is acetic acid.
  3. 3. the synthetic method of 3-amino-8-Trifluoromethylquinocarboxylic according to claim 1, is characterized in that: the temperature of reaction of step 1 is 110 DEG C, the reaction times is 12h.
  4. 4. the synthetic method of 3-amino-8-Trifluoromethylquinocarboxylic according to claim 1, is characterized in that: in step 1, the mol ratio of 8-Trifluoromethylquinocarboxylic and N-bromosuccinimide is 1:1.2.
  5. 5. the synthetic method of 3-amino-8-Trifluoromethylquinocarboxylic according to claim 1, is characterized in that: it is reaction solvent that step 2 adopts Isosorbide-5-Nitrae-dioxane.
  6. 6. the synthetic method of 3-amino-8-Trifluoromethylquinocarboxylic according to claim 1, it is characterized in that: in step 2, the mol ratio of each substrate is the bromo-8-Trifluoromethylquinocarboxylic of 3-: t-butyl carbamate: cesium carbonate: 4, two diphenylphosphine-9 of 5-, 9-dimethyl oxa-anthracene: palladium=1:1.1:2:0.1:0.055.
  7. 7. the synthetic method of 3-amino-8-Trifluoromethylquinocarboxylic according to claim 1, is characterized in that: the temperature of reaction of step 2 is 90 DEG C, the reaction times is 4h.
CN201410363728.0A 2014-07-29 2014-07-29 Synthesis method of 3-amino-8-trifluoromethyl quinoline Pending CN104163798A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410363728.0A CN104163798A (en) 2014-07-29 2014-07-29 Synthesis method of 3-amino-8-trifluoromethyl quinoline

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410363728.0A CN104163798A (en) 2014-07-29 2014-07-29 Synthesis method of 3-amino-8-trifluoromethyl quinoline

Publications (1)

Publication Number Publication Date
CN104163798A true CN104163798A (en) 2014-11-26

Family

ID=51907801

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410363728.0A Pending CN104163798A (en) 2014-07-29 2014-07-29 Synthesis method of 3-amino-8-trifluoromethyl quinoline

Country Status (1)

Country Link
CN (1) CN104163798A (en)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112375037A (en) * 2020-09-01 2021-02-19 苏州康润医药有限公司 Synthetic method of 3-amino-5-bromoquinoline
CN114409515A (en) * 2021-12-09 2022-04-29 南京工业大学 Preparation method of gem-difluoroolefin compound

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1396833A (en) * 2000-02-03 2003-02-12 卫材株式会社 Integrin expression inhibitors
CN102448959A (en) * 2009-05-26 2012-05-09 雅培制药有限公司 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1396833A (en) * 2000-02-03 2003-02-12 卫材株式会社 Integrin expression inhibitors
CN102448959A (en) * 2009-05-26 2012-05-09 雅培制药有限公司 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases

Non-Patent Citations (5)

* Cited by examiner, † Cited by third party
Title
ANDRES A. TRABANCO: "Fluorous-Tagged Carbamates for the Pd-Catalyzed Amination of Aryl Halides", 《J. ORG. CHEM.》, vol. 72, 18 September 2007 (2007-09-18), pages 8146 - 8148 *
JINGJUN YIN: "Palladium-Catalyzed Intermolecular Coupling of Aryl Halides and Amides", 《ORGANIC LETTERS》, vol. 2, no. 8, 22 March 2000 (2000-03-22), pages 1101 - 1104, XP002413650, DOI: doi:10.1021/ol005654r *
MOHAMED ALI SOUSSI: "Discovery of azaisoerianin derivatives as potential antitumors agent", 《EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY》, vol. 78, 13 March 2014 (2014-03-13), pages 178 - 189, XP028847841, DOI: doi:10.1016/j.ejmech.2014.03.032 *
RYAN A ALTMAN: "Pd-catalyzed amination reactions of aryl halides using bulky biarylmonophosphine ligands", 《NATURE PROTOCOLS》, vol. 2, no. 11, 30 November 2007 (2007-11-30), pages 2881 - 2887 *
吴警: "N-溴代丁二酰亚胺在有机反应中的研究进展", 《广州化工》, vol. 39, no. 9, 30 September 2011 (2011-09-30), pages 31 - 34 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112375037A (en) * 2020-09-01 2021-02-19 苏州康润医药有限公司 Synthetic method of 3-amino-5-bromoquinoline
CN112375037B (en) * 2020-09-01 2022-04-12 苏州康润医药有限公司 Synthetic method of 3-amino-5-bromoquinoline
CN114409515A (en) * 2021-12-09 2022-04-29 南京工业大学 Preparation method of gem-difluoroolefin compound

Similar Documents

Publication Publication Date Title
CN102020633B (en) Method for preparing 1-(3,5- dichloropyridine-2-yl)-pyrazolecarboxamide compounds
CN106366072B (en) A kind of preparation method of AZD9291
CN110526859B (en) Revinanexin intermediate, preparation method thereof and preparation method of Revinanexin
CN103601686A (en) Method for synthesizing fluorine-containing pyrimidine compounds by virtue of one-pot method
CN106366022A (en) Intermediate used for AZD9291 preparation, and preparation method and application thereof
CN102491974B (en) Method for synthesizing 1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-formamidine hydrochloride
CN104447547A (en) Synthesis method of 4-aminoisoquinoline-8-methyl formate
CN102367260A (en) Synthesis method of 2-aminopyrimidine-5-boric acid
CN102351778A (en) Preparation method of arbidol hydrochloride
CN103360374A (en) Synthesis method of vilazodone and salt thereof
CN109748902B (en) Preparation method of erlotinib hydrochloride
CN104163798A (en) Synthesis method of 3-amino-8-trifluoromethyl quinoline
CN101654419A (en) Preparation method of fluvoxamine maleate
CN114805327A (en) Intermediate for thiohydantoin medicine and preparation method and application thereof
CN107935997A (en) A kind of difficult to understand this replaces the synthetic method of Buddhist nun
CN104311485A (en) Preparation method of medicine bosutinib for treating leukemia
CN105601529B (en) The synthetic method of pretilachlor
CN106831549B (en) A kind of method of asymmetric synthesis of Claritin carbinoxamine
CN106588921B (en) A kind of synthetic method of the methyl formate of 7 azaindole 3
CN104774202A (en) Synthesis method of 9H-pyridino[2,3-b]indole compounds
CN104447543A (en) 3-amino-7,8-difluoroquinoline and synthesis method of intermediate body of 3-amino-7,8-difluoroquinoline
CN103755657B (en) A kind of preparation method of Rivaroxaban intermediate
CN103360373A (en) Synthesis method of vilazodone intermediate and salt thereof
CN104177293A (en) Synthesis method of 5-amino-7-trifluoromethyl quinoline and 5-trifluoromethyl-7-amino quinoline
CN106279114B (en) A kind of synthetic method of Taladegib

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication

Application publication date: 20141126

RJ01 Rejection of invention patent application after publication